239 related articles for article (PubMed ID: 18816010)
1. Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.
Jaurrieta N; Jimenez-Murcia S; Menchón JM; Del Pino Alonso M; Segalas C; Alvarez-Moya EM; Labad J; Granero R; Vallejo J
Psychother Res; 2008 Sep; 18(5):604-14. PubMed ID: 18816010
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
3. Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study.
O'Connor K; Todorov C; Robillard S; Borgeat F; Brault M
Can J Psychiatry; 1999 Feb; 44(1):64-71. PubMed ID: 10076743
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX
J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
[TBL] [Abstract][Full Text] [Related]
5. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
7. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
8. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons.
Skarphedinsson G; Hanssen-Bauer K; Kornør H; Heiervang ER; Landrø NI; Axelsdottir B; Biedilæ S; Ivarsson T
Nord J Psychiatry; 2015 Feb; 69(2):81-92. PubMed ID: 25142430
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
10. Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: follow up.
Jaurrieta N; Jiménez-Murcia S; Alonso P; Granero R; Segalàs C; Labad J; Menchón JM
Psychiatry Clin Neurosci; 2008 Dec; 62(6):697-704. PubMed ID: 19068007
[TBL] [Abstract][Full Text] [Related]
11. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.
Tolin DF; Abramowitz JS; Diefenbach GJ
J Clin Psychiatry; 2005 Dec; 66(12):1549-57. PubMed ID: 16401156
[TBL] [Abstract][Full Text] [Related]
12. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
[TBL] [Abstract][Full Text] [Related]
13. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
[TBL] [Abstract][Full Text] [Related]
14. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
Tolin DF; Maltby N; Diefenbach GJ; Hannan SE; Worhunsky P
J Clin Psychiatry; 2004 Jul; 65(7):922-31. PubMed ID: 15291681
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
[TBL] [Abstract][Full Text] [Related]
18. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
[TBL] [Abstract][Full Text] [Related]
19. Early maladaptive schemas impact on long-term outcome in patients treated with group behavioral therapy for obsessive-compulsive disorder.
Sunde T; Hummelen B; Himle JA; Walseth LT; Vogel PA; Launes G; Haaland VØ; Haaland ÅT
BMC Psychiatry; 2019 Oct; 19(1):318. PubMed ID: 31655556
[TBL] [Abstract][Full Text] [Related]
20. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
